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Abstract:  During the peri-ovulatory period the cervix relaxes in response to changes in 19 
circulating concentrations of reproductive hormones.  The present study investigated the role of 20 
gonadotrophins in cervical function by examining the expression of FSHR and LHR and their 21 
mRNAs following intra-cervical treatment with either FSH or LH.  Eighteen ewes were 22 
assigned to 4 groups they were then treated with progestagen sponges and PMSG to 23 
synchronize their oestrous cycles.  Intra-cervical treatments were given 24h after sponge 24 
removal as follows: Group 1: FSH 2 mg; Group 2: LH 2 mg; Group 3: Vehicle and Group 4: 25 
Control.  Cervices were collected 54h after sponge removal and then divided into 3 regions.  26 
The expression of FSHR and LHR was determined by immunohistochemistry and FSHR 27 
mRNA and LH mRNA by in situ hybridization. The expression of LHR, FSHR and their 28 
respective mRNAs was compared in 6 tissue layers (luminal epithelium, sub-epithelial stroma, 29 
circular, longitudinal and transverse muscle and serosa) and in 3 cervical regions (vaginal, mid 30 
and uterine).  The results showed that FSH increased transcription of the FSHR gene and the 31 
levels of its receptor but only in sub-epithelial stroma of the cervix.  FSH also increased the 32 
levels of LHR in the cervix but only in the muscle layers.  LH had no effect on the levels of 33 
FSHR despite the fact that it did increase the level of transcription of the FSHR gene and LH 34 
also increased the levels of its own receptor in the cervix but only in the muscle layers and this 35 
action was independent of increased levels of transcription of the LHR gene.  These findings 36 
suggest multiple levels of regulation of cervical LH and FSH receptors and that the 37 
gonadotrophins may have a role in relaxation of the cervix during oestrus by regulating their 38 
own receptors. 39 
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41 
Introduction 42 
One of the main purposes of artificial insemination in sheep breeding is to increase the rate of 43 
genetic improvement. However, conventional trans-cervical insemination in sheep gives poor 44 
fertility mainly because of the unusual anatomy of the sheep cervix.  The ovine cervix is a long, 45 
fibrous and convoluted tubular organ that prevents easy passage of an insemination pipette 46 
through the cervical lumen (Halbert et al., 1990).  There is a degree of natural relaxation at 47 
oestrus (Leethongdee et al., 2007b) that is probably regulated by the peri-ovulatory changes in 48 
reproductive hormones (Kershaw et al., 2004). The cervix contains receptors for oestradiol, 49 
progesterone, oxytocin (Fuchs et al., 1996) as well as those for Luteinizing hormone (LH) and 50 
Follicle stimulating hormone (FSH) (Mizrachi and Shemesh, 1999b, 1999a; Fields and 51 
Shemesh, 2004) suggesting that the gonadotrophins may have a functional role in cervical 52 
physiology at oestrus.  53 
 54 
There is good evidence indicating that cervical relaxation is mediated by Prostaglandin E2 55 
(PGE2) (Fuchs et al., 2002; Feltovich et al., 2005), and the peri-ovulatory changes in 56 
reproductive hormones are associated with increased levels  of cervical COX-2 (Kershaw et al., 57 
2007; Kershaw-Young et al., 2009a) and increased cervical synthesis of PGE2 (Falchi et al., 58 
2009). Similarly in the cow, cervical relaxation during oestrus is mediated by a local increase in 59 
Cyclooxygenase-2 (COX-2) and a subsequent increase in PGE2 production by the cervix 60 
(Shemesh et al., 1997a).  Prostaglandin E2 separates collagen fibres causing reduced tensile 61 
strength of the cervix (Feltovich et al., 2005) thus allowing the cervical canal to dilate. 62 
Naturally occurring cervical relaxation at oestrus is probably the result of complex interactions 63 
among reproductive hormones acting on the cervix.  An increase in the levels of receptors for 64 
oestradiol and oxytocin during the peri-ovulatory period is thought to mediate increased 65 
synthesis of PGE2 (Shemesh et al., 1997a) leading to remodeling of the extracellular matrix 66 
(ECM) (Stys et al., 1981; Ledger et al., 1983) and cervical relaxation.  67 
 68 
Gonadotrophin receptors have been identified in the cervix of the cow and both FSH receptor 69 
(FSHR) and its mRNA are highest during pro-oestrus and oestrus (Mizrachi and Shemesh, 70 
1999b) at a time when circulating FSH is also high (Shemesh, 2001). Similarly, LHR and its 71 
mRNA are also present in the cervix of cows (Shemesh et al., 1997b; Mizrachi and Shemesh, 72 
1999a). The presence of LH receptor (LHR) has been reported in women (Lin et al., 2003) and 73 
furthermore intra-cervical human chorionic gonadotrophin (hCG) increased the levels of cAMP 74 
and COX-2 in the human cervix (Lin et al., 2003).  A role for the gonadotrophins in the process 75 
of cervical relaxation although implied by the presence of their receptors and some downstream 76 
mediators remains unidentified. 77 
 78 
There is very little data on the action of gonadotrophins in the ovine cervix although in a 79 
previous study (Leethongdee et al., 2007a) we showed that the local application of FSH and/or 80 
an analogue of PGE (Misoprostol) enhanced the penetrability of the cervix (Leethongdee et al., 81 
2007b). Consequently we set out to determine the actions of FSH and LH on the ovine cervix 82 
during the peri-ovulatory period of the oestrous cycle.  Our hypothesis was that FSH and/or LH 83 
are involved in the regulation of cervical relaxation during the peri-ovulatory period.  The study 84 
described in this paper was an examination of the effects of intra-cervical gonadotrophins on 85 
the intra-cervical levels of LHR and FSHR protein and mRNA. 86 
 87 
Materials and Methods 88 
Animals and their management 89 
In this study 18 adult Welsh Mountain ewes were divided randomly into two groups of 5 and 90 
two groups of 4 ewes. They were all healthy and had body condition scores between 2.5 and 91 
3.5 and a mean body weight of 37.8 kg with range of 32 to 42 kg. During the experiment the 92 
animals were housed indoors, in groups, on straw and were fed with a commercial concentrate 93 
diet ad libitum and with hay and water always available. All the experimental procedures with 94 
ewes were conducted with the approval of the ethics committee of the Royal Veterinary 95 
College, University of London and with authorization from the Home Office (United Kingdom) 96 
in compliance with the Animal (Scientific Procedures) Act, 1986. 97 
 98 
Intra-cervical administration of FSH or LH  99 
The ewes were synchronized to a common day of oestrus using intra-vaginal sponges 100 
containing 30 mg of fluorogestone acetate (Chronogest; Intervet UK Ltd, Northamptonshire, 101 
UK) for 12 days. The experiment was conducted during the non-breeding season (March to 102 
April) therefore, ewes were injected intramuscularly with 500IU of pregnant mare serum 103 
gonadotrophin (PMSG; Intervet UK Ltd., Buckinghamshire, UK), at the time of removal of 104 
sponges. Ovine FSH (2 mg Ovagen; ICPbio (UK) Limited, Wiltshire, UK) or ovine LH (2 mg, 105 
Sigma-Aldrich Chemie GmbH, Steinheim, Germany) were dissolved in 0.5 ml of 50% gum 106 
acacia (Sigma-Aldrich Chemie GmbH, Steinheim, Germany) in normal saline and intra-107 
cervical treatments were applied 24 h after removal of the sponges as follows: Group 1, FSH (2 108 
mg) , Group 2, LH (2 mg), Group 3, gum vehicle and Group 4, no vehicle (the procedure was 109 
carried out but no vehicle was deposited in the cervix). 110 
 111 
Collection of cervical tissue 112 
Ewes were killed 54 h after removal of sponges (i.e. 30h after treatment) with a captive bolt 113 
pistol followed by exsanguination.  The reproductive tract was removed immediately after 114 
death, and kept on ice.  All unwanted tissue was trimmed from the cervix which was then 115 
divided into 3 approximately equal, transverse segments (Kershaw et al., 2007; Kershaw-116 
Young et al., 2009b; Leethongdee et al., 2010) representing the uterine, middle, and vaginal 117 
regions of the cervix. The segments were fixed in neutral-buffered formalin (BDH, VWR 118 
International Ltd., Leicestershire, UK) for 24h, and then stored in 70% ethanol.  Fixed tissues 119 
were embedded in paraffin wax; sections were cut at 7µm on a rotary microtome and mounted 120 
onto Superfrost Plus slides (BDH, VWR International Ltd., Leicestershire, UK).  121 
 122 
The determination of FSHR and LHR mRNA 123 
The levels  of mRNA for FSHR and LHR was determined by in situ hybridization (ISH) using 124 
digoxigenin-11-UTP labeled sense and antisense riboprobes for ovine LHR and bovine FSHR 125 
as described for our laboratory (Kershaw et al., 2007; Ponglowhapan et al., 2007; 126 
Ponglowhapan et al., 2008; Leethongdee et al., 2010).  The sense and antisense riboprobes for 127 
FSHR and LHR were made by transcribing the N-terminus sequence of bovine FSHR and 128 
ovine LHR complementary deoxyribonucleic acid (cDNA), supplied by Professor Allen 129 
Garverick of the University of Missouri-Columbia, Columbia, Missouri, USA (Xu et al., 1995). 130 
The cDNAs for FSHR and LHR were cloned into the PGEM-Teasy plasmid (Promega 131 
Corporation, Madison, USA). Riboprobes were synthesized with the SP6 and T7 MEGAscript 132 
transcription kits (Ambion Ltd, Cambridgeshire, UK) and labeled with digoxigenin-11-UTP 133 
(Roche Diagnostics, Mannheim, Germany). In-situ hybridizations for FSHR and LHR mRNAs 134 
were performed on four sections (one sense and three antisense) from the each of the uterine, 135 
middle, and vaginal regions of the cervix for each ewe using the protocol described in our 136 
previous studies (Kershaw-Young et al., 2009b; Kershaw-Young et al., 2010; Leethongdee et 137 
al., 2010). Both riboprobes were hybridized at 65°C for 3 h.  138 
 139 
The determination of FSHR and LHR protein 140 
The procedure for the immunohistochemical localization was the same as described for our 141 
laboratory (Ponglowhapan et al., 2008; Perry et al., 2010; Perry et al., 2012). 142 
Immunoperoxidase staining was used to determine the level of  LHR and FSHR protein using 143 
the polyclonal antibodies for FSHR (H-190, sc-13935) and LHR (H-50, sc-25828; both from 144 
Santa Cruz Biotechnology Inc., Santa Cruz, California, USA).  Sections from the uterine, 145 
middle and vaginal regions of the cervix from each animal were examined in triplicate for both 146 
positive antibody staining and negative controls. The binding site of the enzyme was stained  147 
with diaminobenzidine-based peroxidase substrate (ImmPAC™ DAB, Vector Laboratory Ltd, 148 
Cambridgeshire, England), then counterstained with Hematoxylin (Hematoxylin QS, catalogue 149 
number H-3404, Vector Laboratory Ltd, Cambridgeshire, England). Negative controls were 150 
performed in the same manner but substituting the primary antibody with the non-immune 151 
rabbit IgG (Santa Cruz Biotechnology, Santa Cruz, California, USA) at an equivalent 152 
concentration.  153 
 154 
Quantification of in-situ hybridization and immunohistochemistry staining 155 
The levels of both mRNA and protein for FSHR and LHR were assessed blind in five tissue 156 
layers of the cervix, namely the luminal epithelium, sub-epithelial stroma, circular smooth 157 
muscle, longitudinal smooth muscle and transverse smooth muscle as described in our previous 158 
studies (Ponglowhapan et al., 2007; Ponglowhapan et al., 2008; Leethongdee et al., 2010; Perry 159 
et al., 2010; Perry et al., 2012). The five cell layers in each region of the cervix were scored for 160 
both the percentage of cells stained and the intensity of staining as described and validated in 161 
previous publications from our laboratory (Ponglowhapan et al., 2007; Ponglowhapan et al., 162 
2008; Leethongdee et al., 2010; Perry et al., 2010; Perry et al., 2012).   163 
 164 
Statistical analysis 165 
The results are presented as means and the pooled standard error of the difference (S.E.D).  The 166 
effects of treatment, region and tissue layer as well as their interactions were analyzed using a 167 
mixed model ANOVA.  Sheep were treated as subjects with cervical region and tissue layer as 168 
repeated measures and hormonal treatment as a fixed factor.  Where it was appropriate, 169 
additional post-hoc tests comparing the effects of treatment within either cervical regions or 170 
cervical layers were made using the Bonferroni test.  The tests were carried out using SPSS for 171 
Windows (SPSS version 20.0; SPSS Inc., IBM Company Headquarters, Chicago, Illinois, 172 
USA). Differences were considered statistically significant when P ≤ 0.05. 173 
 174 
Results 175 
Cervical Layer 176 
There were no significant interactions of cervical layer with either hormonal treatment or the 177 
region of the cervix for any of the 4 endpoints (FSHR, LHR, FSH mRNA and LHR mRNA) 178 
and the overall effects of cervical layer are presented in anatomical order from the inner 179 
luminal epithelium to the outermost layer of smooth muscle (Figure 1). There was no 180 
expression detected for any of the endpoints in the outer serosal layer and therefore it has been 181 
omitted from the figure.  In general the level of expression was highest in the luminal 182 
epithelium and lowest in the sub-epithelial stroma with the three muscle layers intermediate 183 
(Figure 1). However, there were exceptions to this layer generalization.  For FSHR, the mean 184 
expression in the sub-epithelial stroma was lower (all <0.01) than all other layers which were 185 
not significantly different from each other (epithelium; circular muscle; longitudinal muscle 186 
and transverse muscle (Figure 1).  For LHR, mean expression in the luminal epithelium was 187 
higher (all <0.01) than all other layers which were not significantly different from each other 188 
(Figure 1). 189 
 190 
For FSHR mRNA, mean expression in transverse muscle was lower (all <0.01) than the other 191 
muscle layers (circular muscle and longitudinal muscle) and the epithelium but not the sub-192 
epithelial stroma and the sub-epithelial stroma was not significantly different from any of the 193 
other layers (Figure 1).   For LHR mRNA, mean expression in the sub-epithelial stroma was 194 
lower (all <0.01) than all other layers which were not significantly different from each other 195 
(Figure 1). 196 
 197 
Figure 1: The Mean level (expression index) and the standard error of the difference (SED) for FSHR, LHR and their mRNAs in the five 198 
layers (presented in anatomical order from the inner luminal epithelium to the outer transverse muscle layer) of the sheep cervix after intra-199 
cervical treatment with FSH, LH, vehicle or no treatment (controls).   Columns with different letters differ significantly at P<005. 200 
201 
Cervical Region 202 
For FSHR and LHR there were no significant interactions of cervical region with hormonal 203 
treatment or cervical layer and the overall effects of cervical region for these two endpoints are 204 
presented in Figure 2.  The expression indices for FSHR and LHR were not significantly 205 
different among the regions of the cervix (Figure 2).  Similarly for FSHR mRNA, the level of 206 
expression did not vary among the regions (Figure 2).  However, for LHR mRNA, mean 207 
expression was greater at the vaginal end of the cervix compared to either the middle-region (P 208 
<0.01) or the uterine end (P <0.05 – Figure 2). 209 
 210 
Figure 2: The Mean level (expression index) and the standard error of the difference (SED) for FSHR, LHR and their mRNAs in three regions 211 
of the sheep cervix after intra-cervical treatment with FSH, LH, vehicle or no treatment (controls).  Columns with different letters differ 212 
significantly at P<005. 213 
214 
Hormonal Treatments 215 
The main effects of intra-cervical application of FSH and LH on the cervical expression of FSH 216 
and LH proteins and mRNAs are summarized in Table 1. 217 
Follicle Stimulating hormone (FSH) 218 
Intra-cervical FSH increased the overall expression of FSHR (Figure 3) compared to either the 219 
vehicle-treated (P = 0.006) or control groups (P = 0.003).  Post-hoc paired comparisons showed 220 
that the effect of FSH was confined to the layer of sub-epithelial stroma at the uterine end of 221 
the cervix when compared to either the vehicle-treated (P = 0.008) or control groups (P = 222 
0.003) and there was no effect in the epithelium or the muscle layers.  There were significant 223 
effects of intra-cervical FSH on the level of cervical FSHR mRNA compared to vehicle-treated 224 
(P <0.001) and control (P <0.001) groups).  The effect of FSH was seen in all layers and 225 
regions of the cervix (Figure 3). 226 
 227 
Intra-cervical FSH also increased LHR in all regions of the cervix compared to vehicle-treated, 228 
(P <0.001) and control, (P <0.001) groups (Figure 3).  Post-hoc paired comparisons revealed 229 
that the effect was confined to the smooth muscle layers (circular muscle, P = 0.018 compared 230 
to vehicle-treated and P = 0.004 compared to controls; longitudinal muscle, P = 0.009 231 
compared to vehicle-treated and P = 0.002 compared to controls and transverse muscle, P = 232 
0.026 compared to vehicle-treated and P = 0.002 compared to controls).  There was no 233 
significant effect in either the sub-epithelial stroma or the luminal epithelium.  By contrast 234 
there was no effect of intra-cervical FSH on the expression of LHR mRNA (Figure 3). 235 
Luteinizing Hormone (LH) 236 
Intra-cervical LH had no effect cervical FSHR (Figure 3) when compared to either the vehicle-237 
treated (P = 0.164) or control groups (P = 0.108).  By contrast intra-cervical LH increased the 238 
level of FSHR mRNA compared to the vehicle-treated (P = 0.001) and control groups (P < 239 
0.001) and the effect was seen in all regions and layers of the cervix (all P values at least P = 240 
0.007).  241 
 242 
Figure 3: The Mean level (expression index) and the standard error of the difference (SED) for FSHR, LHR and their mRNAs in the sheep 243 
cervix after intra-cervical treatment with FSH, LH, vehicle or no treatment (controls).  Columns with different letters differ significantly at 244 
P<005. 245 
246 
Intra-cervical LH increased the overall expression of LHR in the cervix (Figure 3). Post-hoc 247 
paired comparisons revealed that the effect was confined to the uterine end of the cervix 248 
(vehicle-treated, P = 0.001; control, P <0.001).  Furthermore, the effect of LH on the levels of 249 
its receptor was confined to the three muscle layers (circular muscle, P = 0.010 for vehicle-250 
treated and P = 0.002 for controls; longitudinal muscle, P = 0.013 for vehicle-treated and P = 251 
0.003 for controls and transverse muscle, P = 0.039 for vehicle-treated and P = 0.003 for 252 
controls) and it was not seen in either the sub-epithelial stroma or epithelium.  By contrast 253 
intra-cervical LH had no effect on the expression of LHR mRNA.  Although was an apparent 254 
effect compared to control ewes (P = 0.011; Figure 3) there was no effect compared to vehicle 255 
treated-ewes (P = 0.196) indicating a non-specific effect of the vehicle (Figure 3). 256 
 257 
Correlations 258 
The level of expression of FSHR was positively correlated with that of FSHR mRNA (r = 259 
0.358; P <0.001) and similarly the level of expression of LHR was positively correlated with 260 
that of LHR mRNA (r = 0.321; P <0.001). There was also a significant positive correlation 261 
between the levels of expression of FSHR mRNA and LHR mRNA (r = 0.459; P <0.001). 262 
 263 
Discussion 264 
In this study, levels of the FSHR and LHR and their mRNAs were determined using the semi 265 
quantitative techniques of in situ hybridization for mRNA and immunohistochemistry for 266 
protein.  For both techniques we used a scoring system that has been previously validated and 267 
successfully used in our laboratory (Kershaw et al., 2007; Ponglowhapan et al., 2008; 268 
Leethongdee et al., 2010).  Using these techniques, our study confirmed the presence of both 269 
FSHR and LHR proteins and their mRNAs in the ovine cervix during the follicular phase of the 270 
oestrous cycle (Leethongdee et al., 2010).  Furthermore the results also showed that the cervical 271 
levels of FSHR, LHR and their receptors can be altered by the intra-cervical application of FSH 272 
or LH suggesting that the gonadotrophins may have a functional role in the cervix of the 273 
oestrous ewe.  However, what those functions might be and their mechanisms of action were 274 
beyond the scope of this investigation. 275 
 276 
Anatomically, the cervix consists of six broadly concentric tissue layers from an inner luminal 277 
epithelium with its underlying sub-epithelial stroma that is surrounded by three layers of 278 
smooth muscle (circular, longitudinal and transverse) and encased in an outermost serosal 279 
layer.  Both FSHR and LHR and their mRNA were detected in all cervical layers except the 280 
outer serosal layer.  In general, expression tended to be highest in luminal epithelium and 281 
lowest in the sub-epithelial stroma and with intermediate levels of expression in the layers of 282 
smooth muscle and within smooth muscle expression tended to be higher in the innermost 283 
circular and longitudinal layers and lower in the outer transverse layer.  The presence of FSH 284 
and LH receptors in the luminal epithelium, sub-epithelial stroma and in the layers of smooth 285 
muscle but, not in the serosa show that the gonadotrophins have three distinct target cells 286 
(luminal epithelium; sub-epithelial stroma and smooth muscle) in the cervix and furthermore 287 
the results demonstrated cell specific patterns of distribution of FSHR and LHR and their 288 
mRNAs suggesting that the gonadotrophins have distinct functions in these cervical cell types 289 
that may affect the physiological control of cervical function in the oestrous ewe. 290 
 291 
Although there were specific differences in the level of expression among the cellular layers of 292 
the cervix, in general there were no effects among the regions of the cervix except for LHR 293 
mRNA whose expression was higher at the vaginal end of the cervix.  These findings agree 294 
with those of our earlier study (Leethongdee et al., 2010) that showed higher levels of LH 295 
mRNA at the vaginal end of the cervix but no differences in the level of expression of FSH 296 
mRNA among the regions of the cervix. 297 
 298 
Intra-cervical FSH increased FSHR but only at the uterine end of the cervix and then only in 299 
the sub-epithelial stroma of the cervix; there was no effect in the luminal epithelium or the 300 
layers of smooth muscle.  However, the administration of intra-cervical FSH increased FSHR 301 
mRNA throughout the cervix.  These data show that in the sub-epithelial stroma the level of 302 
expression of FSHR mRNA was associated with increased levels of FSHR protein but, that in 303 
the luminal epithelium and in the layers of smooth muscle increased gene transcription was not 304 
translated into increased levels of receptor protein.  Intra-cervical FSH also increased LHR in 305 
all regions of the cervix but, its effect was confined to the three layers of smooth muscle and it 306 
was not seen in either the sub-epithelial stroma or luminal epithelium.  By contrast there was no 307 
effect of intra-cervical FSH on the expression of LHR mRNA in any region or layer of the 308 
cervix.  These results show that although FSH increased the level of expression of LHR in the 309 
cervix it did so independently of gene transcription.   Overall the variability in the pattern of 310 
response to intra-cervical FSH suggest that FSH has distinct mechanisms of action in the, sub-311 
epithelial stroma and the smooth muscle layers of the cervix involving effects on gene 312 
transcription and post-transcriptional effects on gonadotrophin receptors. We can conclude that 313 
although intra-cervical FSH stimulated FSHR and LHR gene expression throughout the cervix 314 
it increased the level of its own receptor only in the sub-epithelial stroma and that of LHR only 315 
in smooth muscle. 316 
 317 
The intra-cervical application of LH did not affect FSHR in any region or layer of the cervix.  318 
However, intra-cervical LH increased the level of FSHR mRNA in all regions and layers of the 319 
cervix again suggesting that increased transcription of the FSHR gene was not translated into 320 
increased levels of receptor protein.  Intra-cervical LH did increase the expression of LHR in 321 
the uterine region of the cervix but, similarly to intra-cervical FSH, its effect was confined to 322 
the layers of smooth muscle.  Again similarly to intra-cervical FSH, intra-cervical LH had no 323 
effect on the expression of LHR mRNA in any region or layer of the cervix suggesting an 324 
effect of LH on its own receptor that is also independent of gene transcription.  We can 325 
conclude that in the cervix LH has no effect on FSHR protein and that its effect on LHR protein 326 
is restricted to smooth muscle and that it is post-transcriptional. 327 
 328 
Despite the presence of LHR, FSHR and their mRNAs in the luminal epithelium of the cervix 329 
we did not observe any effects of either intra-cervical FSH or LH on their patterns of 330 
expression.  The reasons for this are not apparent from this experiment, perhaps the high 331 
concentrations of gonadotrophins in the cervical canal and thus closest to the luminal 332 
epithelium may have an inhibitory action. 333 
 334 
Although cervical receptors for FSH have been observed in the cow (Mizrachi and Shemesh, 335 
1999a, 1999b) and the ewe (Leethongdee et al., 2010) and for LH in the cow (Kornyei et al., 336 
1993; Mizrachi and Shemesh, 1999a; Stepien et al., 2000; Lin et al., 2003) and the ewe 337 
(Leethongdee et al., 2010) relatively little is known of the possible roles of LH and FSH in the 338 
control of cervical function at oestrus.  The potential role of FSH in cervical function has been 339 
examined in the non-pregnant cow using cultured cervical tissue (Mizrachi and Shemesh, 340 
1999b).  These authors showed that the level of FSHR in the cervix was greatest during the 341 
follicular phase of the oestrous cycle (Mizrachi and Shemesh, 1999b) and similar effects were 342 
reported for LH (Mizrachi and Shemesh, 1999a, 1999b; Shemesh et al., 2001).  The mechanism 343 
of action of gonadotrophins in the ovine cervix has not been investigated.  However, because 344 
the action of LH in the bovine uterus is mediated by the cAMP/protein kinase A signaling 345 
pathway (Kornyei et al., 1993) it is possible that the same pathway mediates the cervical 346 
actions of LH in the ewe. 347 
 348 
Relaxation of the cervix is due to a complex combination of biochemical and structural changes 349 
affecting cervical connective tissue, that transforms the cervix into an extensible organ 350 
(Uldbjerg et al., 1983).  The application of exogenous PGE induces softening of the cervix 351 
making it more extensible and suggesting that the control of cervical extensibility is mediated 352 
by prostaglandins (Fuchs et al., 1984; Ji et al., 2008).  There is considerable evidence showing 353 
that prostaglandin E2 probably mediates this effect in the non-pregnant ewe (Falchi et al., 354 
2009) through the rearrangement of collagen bundles in the cervical extra cellular matrix 355 
(Kershaw et al., 2007). The prostaglandin system in sheep cervix is mainly regulated by, COX-356 
2 (Diaz et al., 1992) and level of COX-2 mRNA in the sheep cervix was greatest during the 357 
follicular phase of the oestrous cycle (Kershaw et al., 2007; Leethongdee et al., 2007b). This is 358 
a time when the gonadotrophin concentrations are also at their maxima and our findings 359 
suggest that the relation between the follicular phase concentrations of LH and FSH and the 360 
cervical PGE system is a subject well worth further investigation.  361 
 362 
It should be noted that this experiment used intra-cervical application of 2 mg of either FSH or 363 
LH and although the jugular venous concentration of LH and FSH were not increased by these 364 
treatments the local cervical concentrations were not determined but, they may have been 365 
above normal tissue concentrations.  Therefore it is possible that responses observed represent a 366 
pharmacological effect physiological rather than a physiological action.  However, the long 367 
term objective of this research was to develop a therapeutic method to facilitate trans-cervical 368 
artificial insemination. 369 
 370 
Trans-cervical artificial insemination requires the passage of an inseminating pipette through 371 
the cervical canal so that semen can be deposited in the lumen of the uterine body.  Softening 372 
the cervix to make it more extensible (Uldbjerg et al., 1983) or dilating the cervical canal will 373 
both facilitate trans-cervical artificial insemination (Leethongdee et al., 2007b).  Research has 374 
focused on either mechanical (Halbert et al., 1990; Kershaw et al., 2007) or pharmacological 375 
(Leethongdee et al., 2007b; Perry et al., 2010.) techniques to improve the efficiency of trans-376 
cervical artificial insemination.  However, for the moment this remains an intractable problem 377 
(Falchi et al., 2012) and it remains an important objective of research for the sheep breeding 378 
industry.  The tissues implicated in the softening of the cervical canal are the sub-epithelial 379 
stroma and smooth muscle (Kershaw et al., 2007; Kershaw-Young et al., 2010) and the fact that 380 
we have demonstrated effects of exogenous FSH and LH on these two cell types suggest that 381 
gonadotrophin treatment has the potential to facilitate trans-cervical artificial insemination. 382 
 383 
The effects of local FSH and LH on the patterns of expression of FSHR, LHR and their 384 
mRNAS are summarized in table 1.  They show that (i) FSH increased transcription of the 385 
FSHR gene and the levels of its own receptor but the later, only in the sub-epithelial stroma at 386 
the uterine end of the cervix (ii) FSH also increased the levels of LHR in all regions of the 387 
cervix but, only in the layers of smooth muscle and this action was independent of increased 388 
levels of transcription of the LHR gene (iii) LH had no effect on the levels of FSHR despite the 389 
fact that it increased the level of transcription of the FSHR gene and (iv) LH also increased the 390 
level of its own receptor in the uterine end of the cervix but, only in the smooth muscle layers 391 
and this action was independent of increased levels of transcription of the LHR gene. Taken 392 
together, these findings suggest that the gonadotrophins can regulate their own receptors in the 393 
sub-epithelial stroma and smooth muscle of the cervix by multiple mechanisms. 394 
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Table 1:  A summary of the main effects of intra-cervical FSH or LH on the level of expression 525 




Protein mRNA Protein mRNA 
FSH 
Increased in the sub-
epithelial stroma at the 
uterine end of the 
cervix 
 
Increased in all 
layers and all regions 
of the cervix 
 
Increased in the 
three smooth muscle 
layers of all regions  
of the cervix 
No effect in any 
region or layer 
of the cervix 
LH 
No effect in any region 
or layer of the cervix 
Increased in all 
layers and all regions 
of the cervix 
Increased in the 
three smooth muscle 
layers at the uterine 
end of the cervix 
 
No effect in any 
region or layer 
of the cervix 
 528 
529 
Figure legends 530 
Figure 1: The Mean level (expression index) and the standard error of the difference (SED) for 531 
FSHR, LHR and their mRNAs in the five layers (presented in anatomical order from the inner 532 
luminal epithelium to the outer transverse muscle layer) of the sheep cervix after intra-cervical 533 
treatment with FSH, LH, vehicle or no treatment (controls).   Columns with different letters 534 
differ significantly at P<005. 535 
 536 
537 
Figure 2: The Mean level (expression index) and the standard error of the difference (SED) for 538 
FSHR, LHR and their mRNAs in three regions of the sheep cervix after intra-cervical treatment 539 
with FSH, LH, vehicle or no treatment (controls).  Columns with different letters differ 540 
significantly at P<005. 541 
 542 
543 
Figure 3: The Mean level (expression index) and the standard error of the difference (SED) for 544 
FSHR, LHR and their mRNAs in the sheep cervix after intra-cervical treatment with FSH, LH, 545 
vehicle or no treatment (controls).  Columns with different letters differ significantly at P<005. 546 
 547 
